intellectual property


World has moved on from US, EU’s drug monopoly. India and China are changing IP regulations
Even without an IP waiver from the WTO, China and India are leading the challenge to the West’s vaccine monopoly.
The AfCFTA Investment Protocol: preparations for the negotiations and expectations
The preparations for the negotiations of the Investment Protocol under the AfCFTA agreement (The Agreement) are already underway though still in the early stages.
They concern you more than you know: On the perils and potential of international investment agreements for the Agreement on Trade-Related Aspects of Intellectual Property Rights and COVID-19 discussions at the World Trade Organization
Talks on a possible COVID-19-related TRIPS decision aimed at scaling up vaccine and therapeutics production and equitable distribution continue but investment agreements are absent from them.
When free trade is not free
If the states of the world take seriously their own rhetorical commitments to climate change mitigation, job creation, and sustainable development, they must reject the free trade paradigm.
IP, tariffs, data protection to dominate UK-India FTA negotiations
Intellectual Property protection and enforcement, standards, tariffs on several products, and data protection are among the key issues that would dominate the India-UK FTA.
33 groups call for tougher stance on vaccine apartheid in trade negotiations
33 domestic and international groups have written to NZ Prime Minister, calling for NZ to use its bilateral trade negotiations with the United Kingdom and European Union to push for an end to vaccine apartheid.
Investment governance in Africa to support climate resilience and decarbonization
African nations should not be expected to take the lead in addressing a climate emergency they did not create. The priority for Africa is to receive support and investment to build resilience and adapt to climate impacts.
Trade deals pushing UPOV: an interactive map
Which countries use free trade deals to push corporate control over seeds? Which countries are under attack from these deals?
US-China phase-one trade deal gets a reality check after nearly two years
As the two-year deadline for the phase-one trade deal between the world’s two largest economies is approaching, all eyes are on the next step.
‘Clear risk’ UK joining Pacific trade deal will raise drug prices for NHS
There is evidence of a potential conflict between the CPTPP and the UK’s current system of market authorisation of generic and biosimilar drugs.